Total Synthesis of (−)-Caprazamycin A - Wikidata - awgldk - TriplyDB

Total Synthesis of (−)-Caprazamycin A

Total Synthesis of (−)-Caprazamycin A

http://www.wikidata.org/entity/Q57749491

about

Capturing Biological Activity in Natural Product Fragments by Chemical Synthesis

P2860

Q26772873-119B13E3-ED0B-427B-A20A-97CC3B7FED33

P2860

Total Synthesis of (−)-Caprazamycin A

http://www.wikidata.org/entity/Q57749491

description

im Januar 2015 veröffentlichter wissenschaftlicher Artikel

@de

наукова стаття, опублікована в січні 2015

@uk

name

Total Synthesis of (−)-Caprazamycin A

@en

type

label

Total Synthesis of (−)-Caprazamycin A

@en

prefLabel

Total Synthesis of (−)-Caprazamycin A

@en

P1433

Q57749491-1E6A0EFE-4E83-4200-9D41-673B9BA05316

P1476

Q57749491-92D841B0-B1A5-427C-AECC-8863DB1771C9

P2093

Q57749491-0D9DB345-40A2-4C32-BE92-37A69DE3C884

Q57749491-1CD2FBD6-2249-4D3A-A208-ECE2B110767D

Q57749491-241A0A90-C1CE-45B8-A752-857782DF281B

Q57749491-2EC2BD7F-6710-49FB-9E25-449ECC0D014D

Q57749491-DE19F0E4-BFF0-4579-9A04-745269884329

Q57749491-EF418985-1994-4D9E-A231-66069A7EB78D

P2860

Q57749491-06D4C7DC-6A03-44EB-9011-85A8750816D8

Q57749491-1CE24CBD-C830-4584-982C-EE20BC9AF4C3

Q57749491-23E8A106-15BB-42BB-A454-015D441B9F36

Q57749491-2942B80A-ECE2-4398-95AC-2A670A6B3307

Q57749491-35CAD8B3-05D6-4E6A-B549-8E253A89BB72

Q57749491-4DEFB9DA-869D-41AC-83C9-0DBBF93AD562

Q57749491-5500ED03-679A-4490-9F51-3CDE6369246A

Q57749491-55191EFC-22D6-4A5A-9101-47E33B6B3B30

Q57749491-5886674E-2F9B-4348-B1A0-388EF79C760F

Q57749491-864B0452-A8CE-4DD8-ABA3-C64897F5D3F7

P304

Q57749491-DB40B234-6D10-4EB5-8EF7-B61C93000E5A

P31

Q57749491-090133D6-E9E6-463B-9E09-299588A9254C

P356

Q57749491-9FA09FA8-8DEA-47A3-A006-5678235450BA

P433

Q57749491-692CBFD7-5DF2-4B36-AB7D-F9D4E9C78BD4

P478

Q57749491-EB354C3C-2EB2-42ED-A195-1844E2BFE62A

P577

Q57749491-D75B1983-BCD0-436F-8C8D-B42743269E8B

P356

P1433

Angewandte Chemie

P1476

Total Synthesis of (−)-Caprazamycin A

@en

P2093

Chihiro Tsukano

http://www.w3.org/2001/XMLSchema#string

Hugh Nakamura

http://www.w3.org/2001/XMLSchema#string

Masayuki Igarashi

http://www.w3.org/2001/XMLSchema#string

Motohiro Yasui

http://www.w3.org/2001/XMLSchema#string

Shinsuke Yokouchi

http://www.w3.org/2001/XMLSchema#string

Yoshiji Takemoto

http://www.w3.org/2001/XMLSchema#string

P2860

Synthesis of the nucleoside moiety of liposidomycins: elucidation of the pharmacophore of this family of MraY inhibitors.

Novel semisynthetic antibiotics from caprazamycins A-G: caprazene derivatives and their antibacterial activity.

Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis.

A diastereoselective synthesis of 5'-substituted-uridine derivatives.

MraY Inhibitors as Novel Antibacterial Agents.

Inhibition of the first step in synthesis of the mycobacterial cell wall core, catalyzed by the GlcNAc-1-phosphate transferase WecA, by the novel caprazamycin derivative CPZEN-45

Lead structures for new antibacterials: stereocontrolled synthesis of a bioactive muraymycin analogue.

Liquid chromatographic determination of CPZEN-45, a novel anti-tubercular drug, in biological samples

Function-oriented synthesis of simplified caprazamycins: discovery of oxazolidine-containing uridine derivatives as antibacterial agents against drug-resistant bacteria.

Assignment of the liposidomycin diazepanone stereochemistry.

P304

3179-3182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANGE.201411954

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime